Our corporate mission is to discover and develop novel therapeutics with a focus in both cancer and CNS disorders.
A biotechnology company specializing in the discovery and development of innovative therapeutics for cancer and central nervous system (CNS) disorders. It is a wholly owned subsidiary of the Otsuka Group and is headquartered at Cambridge Science Park, UK.